Relationship of Metabolic Alterations and PD-L1 Expression in Cisplatin Resistant Lung Cancer.

Wangpaichitr, M; Kandemir, H; Li, Y Y; Wu, C; Nguyen, Djm; Feun, L G; Kuo, M T; Savaraj, N

Wangpaichitr, M; Kandemir, H; Li, Y Y; Wu, C; Nguyen, Djm; Feun, L G; Kuo, M T; Savaraj, N.

Afiliación

Wangpaichitr M; Miami VA Healthcare System, Research Service, Miami, Florida, USA.
Kandemir H; Department of Surgery, Cardiothoracic Surgery, University of Miami, Miami, Florida, USA.
Li YY; School of Medicine, Koc University, Istanbul, Turkey.
Wu C; Department of Medicine, Hematology/Oncology, University of Miami, Miami, Florida, USA.
Nguyen D; Miami VA Healthcare System, Research Service, Miami, Florida, USA.
Feun LG; Department of Microbiology, University of Miami, Miami, Florida, USA.
Kuo MT; Department of Medicine, Hematology/Oncology, University of Miami, Miami, Florida, USA.
Savaraj N; Department of Translational Molecular Pathology, Texas MD Anderson, Houston, Texas, USA.

Cell Dev Biol ; 6(2)2017 06.

Article en En | MEDLINE | ID: mdl-28819582

Palabras clave

Cisplatin; EMT; Lung cancer; PD-L1; Resistance

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cell Dev Biol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google